A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitInvasive candidiasis as a cause of sepsis in the critically ill patientDiagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemyEmpiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patientsRisk prediction for invasive candidiasisEpidemiology of invasive candidiasis: a persistent public health problemIntensive care medicine research agenda on invasive fungal infection in critically ill patients.Invasive candidiasis: from mycobiome to infection, therapy, and prevention.Effect of antifungal therapy timing on mortality in cancer patients with candidemiaPrognostic factors for candidaemia in intensive care unit patients: a retrospective analysisInvasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Candidemia after cardiac surgery in the intensive care unit: an observational study.Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patientsCanadian clinical practice guidelines for invasive candidiasis in adults.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot studySafety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis.Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICUClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.Invasive candidiasis in non-hematological patients.Septic shock due to candidemia: outcomes and predictors of shock development.Management of invasive candidiasis in nonneutropenic ICU patients.Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.Diagnosis of invasive candidiasis in the ICU.Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study.Invasive fungal disease in PICU: epidemiology and risk factors.Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia.Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-FeverValidation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study.Risk factors for invasive fungal disease in critically ill adult patients: a systematic review.Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
P2860
Q21194915-365F506E-0112-4B3D-89F6-1F7D30867039Q22305429-9EE3948C-AF51-426C-AC60-4B23E4A6CAB4Q26745677-FE5D4E2A-06E0-4FC9-8D76-DA400D05EAEBQ26852351-7D17A524-D4E6-4D8B-B662-E1209E5A26FDQ27023082-9D140D30-B7A5-45C2-9698-265D61F0208BQ29616758-45CC6141-07FF-4F46-9756-D4632F4D488AQ30235457-3A1ADCA4-5758-4A93-936D-C4DA870FAE34Q30251428-796AEEBB-90B5-45A0-B0D3-47AD27D2F2A5Q33559164-C0992D03-5B16-4DD7-B9C9-E8CBC3C552FBQ33567713-BC16653F-F061-4AA3-AAA8-0329029F95D3Q33576580-09A2E826-BF27-4903-8139-E8732E9BDF78Q33595137-AE2BF706-ACD7-41B4-8263-A10A3073460FQ33603993-D67B275D-14AF-4643-8AC5-44769E547265Q33712955-F5458283-4F3D-4C37-BFFC-7092A387B49AQ33779837-B1B5152E-CBEF-4A00-B71F-17FB55728DA8Q33841485-F43359B0-068C-4225-8132-F18E31ED2F66Q34237335-991E7DCF-3DCA-4943-BE1E-2F62B0DA656FQ34374081-EDE8ED5F-475C-49C1-9738-91A450608C29Q34422915-EC539516-D427-4049-8B46-103784DBD61EQ34487220-94697B4A-B7E3-4AA0-B868-8CD78FD7C59DQ34505582-E87546C2-B07E-48BA-A4C8-58F7BAD878D7Q34539213-967FACA7-DE69-4ED8-B16A-12A7169ABFF5Q34596714-46E9073C-9FB4-4131-A655-A33609C13FA6Q35010671-BDB28687-1882-433C-85E9-4945A322A13BQ35119972-ED01B8A7-D0B2-4875-A181-E59FFEAC92BBQ35122093-7F89EB50-85C9-45EC-A4A4-7ED57B2E4747Q35149444-EE9435EA-D9F9-4421-A146-C98EAA0D526BQ35193171-31AB7CE4-FE2F-4B52-9895-FE4F52CF6B2DQ35574038-E3802376-E525-43CA-99A2-B4773D9E3081Q35598171-28FA0EF9-FAE5-4198-BEDF-5F730B1EF9F6Q35636971-1506A597-3AB2-4C07-9179-61457C63890EQ35835858-D7705CDD-24C1-45DB-9336-0818A75B17BEQ35895644-98E22D7F-68A0-45DA-944E-E593FC740682Q35908064-6E7ABF27-8F7A-4CC9-874A-4D0B5D02A7F8Q35908296-330DA20E-CFD7-4C6D-9A9A-F001A6BAE11CQ35960005-039202FE-2F17-42B4-A8DF-79B00F11DCBBQ36040620-4C266809-EF42-4CC2-9BEC-9CE7003ECFDEQ36070524-073D500E-41A2-47DA-8BF5-9EA63C69D096Q36073057-AC782974-6353-4474-89EC-2A04C1D6FAD8Q36128742-3BB1B6BB-1962-4731-8EA7-74684424E35B
P2860
A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A bedside scoring system ("Can ...... nts with Candida colonization.
@en
A bedside scoring system
@nl
type
label
A bedside scoring system ("Can ...... nts with Candida colonization.
@en
A bedside scoring system
@nl
prefLabel
A bedside scoring system ("Can ...... nts with Candida colonization.
@en
A bedside scoring system
@nl
P2093
P1476
A bedside scoring system ("Can ...... nts with Candida colonization.
@en
P2093
Cristóbal León
EPCAN Study Group
Francisco Alvarez-Lerma
Juan Nolla-Salas
María Angeles León
Pedro Saavedra
Sergio Ruiz-Santana
P304
P356
10.1097/01.CCM.0000202208.37364.7D
P407
P577
2006-03-01T00:00:00Z